Related references
Note: Only part of the references are listed.Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis
Thorsten Derlin et al.
CHEST (2021)
Circular RNA CircCDH13 contributes to the pathogenesis of osteoarthritis via CircCDH13/miR-296-3p/PTEN axis
Zhibin Zhou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis
Tachatra Ungsudechachai et al.
CARTILAGE (2021)
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial
Juergen Behr et al.
LANCET RESPIRATORY MEDICINE (2021)
Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury
Yingzhen Du et al.
JOURNAL OF AUTOIMMUNITY (2020)
Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways
Qun Lv et al.
MOLECULAR MEDICINE (2020)
Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts
Yingying Cui et al.
CELLS (2020)
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study
Jorge Luis Poo et al.
HEPATOLOGY INTERNATIONAL (2020)
Astilbin prevents osteoarthritis development through the TLR4/MD-2 pathway
Shuaibo Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Oleanolic Acid Decreases IL-1β-Induced Activation of Fibroblast-Like Synoviocytes via the SIRT3-NF-κB Axis in Osteoarthritis
Jiapeng Bao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
ROR2 blockade as a therapy for osteoarthritis
Anne-Sophie Thorup et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The in vitro anti-fibrotic effect of Pirfenidone on human pterygium fibroblasts is associated with down-regulation of autocrine TGF-β and MMP-1
Yijin Tao et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model
Masao Saito et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
15-Deoxy-Δ-12, 14-prostaglandin J2 acts cooperatively with prednisolone to reduce TGF-β-induced pro-fibrotic pathways in human osteoarthritis fibroblasts
Carlos Vaamonde-Garcia et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Protective effects of quercetin against inflammation and oxidative stress in a rabbit model of knee osteoarthritis
Bing Wei et al.
DRUG DEVELOPMENT RESEARCH (2019)
Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model
Jingwen Guo et al.
TOXICOLOGY LETTERS (2019)
A Three-Dimensional Model to Study Human Synovial Pathology
Mathijs G. A. Broeren et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2019)
Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1
Jin Jin et al.
RESPIRATORY RESEARCH (2019)
3-dimensional metrics of proximal femoral shape deformities in Legg-Calve-Perthes disease and slipped capital femoral epiphysis
Elaine F. Chan et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2018)
cAMP attenuates TGF-β's profibrotic responses in osteoarthritic synoviocytes: involvement of hyaluronan and PRG4
Marwa M. Qadri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Pirfenidone reduces profibrotic responses in human dermal myofibroblasts, in vitro
Caroline L. Hall et al.
LABORATORY INVESTIGATION (2018)
The antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitro
Julie Stougaard et al.
BMC RHEUMATOLOGY (2018)
Synovial Inflammation Drives Structural Damage in Hand Osteoarthritis: a Narrative Literature Review
Luana Mancarella et al.
CURRENT RHEUMATOLOGY REVIEWS (2017)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness
Dennis F. G. Remst et al.
RHEUMATOLOGY (2015)
Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings
Shobu Watanabe et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
The role of synovitis in osteoarthritis pathogenesis
Carla R. Scanzello et al.
BONE (2012)
Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate
Cecile Lambert et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo
Rachael S. Watson et al.
LABORATORY INVESTIGATION (2010)
The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit
S. Laverty et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
Amplifying elements of arthritis and joint destruction
Wim B. van den Berg et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Synovitis score: discrimination between chronic low-grade and high-grade synovitis
V. Krenn et al.
HISTOPATHOLOGY (2006)
Effect of pirfenidone against vanadate-induced kidney fibrosis in rats
MA Al-Bayati et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Share Paper
